Webinar on Opioid and Pain Management: FDA Perspectives and Requirements

Description :

The United States Food and Drug Administration (FDA) recently expressed deep concerns over the growing epidemic of opioid dependence, overuse and abuse on families and communities.

Opioids as prescription drugs are used to reduce chronic pain.  Opioids offer both great benefits and also serious risks, potentially causing serious harm (addiction, overdose and even death) when misused or abused.

This seminar is intended to help industry and professionals to better understand FDA roles and regulation governing controlled substances (opioids) used for pain management. This seminar is also intended to help industry get better familiar with FDA’s recent activity and regulatory expectations for drugs (opioids) including generic opioids and recent approvals for pain management.

The speaker will guide you through the details of FDA roles, regulations, generic opioids and recent FDA approvals for chronic pain management.

Areas Covered in the Session :

Applicable Laws, Regulations and FDA Guidance

Major Misconception

Definitions

Regulations Governing Controlled Substances

Abuse-Deterrent Opioid Medications

Opioid Misuse & Abuse

New Labeling Requirements

FDA Approved Opioids: Generics and ER/LA Opioids

Prevention of Opioid Abuse

Appropriate Pain Management

Speaker’s PASS-IT Recommendations: Best Practices

Who Will Benefit:

Healthcare Practitioners

Pharmacy Professionals

CEOs

VPs

Compliance Officers

Attorneys

Regulatory Affairs

Clinical Affairs

Quality Assurance

Research & Development

Consultants

Contractors/Subcontractors

Anyone Interested in the Opioid and Pain Management